BioCentury
ARTICLE | Company News

Management tracks: Achaogen, Minerva

December 12, 2017 11:41 PM UTC

Antibacterial company Achaogen Inc. (NASDAQ:AKAO) said Kenneth Hillan will step down as CEO, effective Jan. 1. He will remain president and president of R&D. Blake Wise, who has served as president and COO, will become CEO.

Neurology company Minerva Neurosciences Inc. (NASDAQ:NERV) said Remy Luthringer will resign as president, while remaining CEO. Rick Russell will become president. Russell was president and CEO of the North American subsidiary of Stallergenes Greer plc (Euronext:STAGR)...